About Areej El-Jawahri, MD

Dr. El-Jawahri is an oncologist specializing in the care of patients with hematologic malignancies and those undergoing hematopoietic stem cell transplantation. Clinically, she takes care of patients with acute leukemia, myelodysplastic syndrome, chronic leukemias, lymphomas, and myelomas.  Her research interests include investigating patient-reported outcomes, enhancing patient-centered decision-making interventions, and designing supportive care interventions to improve the care of patients with hematologic malignancies with a special emphasis on patients undergoing hematopoietic stem cell transplantation. Her research also explores models of health care delivery to improve patients' quality of life and clinical outcomes. She is an active member of the MGH Cancer Outcomes Research and Education Program (CORE).  She will also leading efforts in building and developing the MGH Bone Marrow Transplantation Survivorship Program.  She has led and conducted multiple clinical trials focusing on enhancing the experience and clinical outcomes of patients with hematologic malignancies.

 

Clinical Interests:

Treats:

Languages:

Locations

Hematology/Oncology Bone Marrow Transplant
55 Fruit St
Boston, MA 02114-2696
617-726-5765
Fax: 617-643-5843

Medical Education

  • MD, Harvard Medical School
  • Residency, Massachusetts General Hospital
  • Fellowship, Dana Farber Cancer Institute

American Board Certifications

  • Internal Medicine, American Board of Internal Medicine
  • Medical Oncology, American Board of Internal Medicine

Accepted Insurance Plans

Note: This provider may accept more insurance plans than shown; please call the practice to find out if your plan is accepted.


Research


Research interests include:

  1. Outcomes and health services research in hematologic malignancies
  2. Designing supportive care interventions for patients with hematologic malignancies and those undergoing hematopoietic stem cell transplantation
  3. Developing interventions to enhance survivorship care for patients with hematologic malignancies and those undergoing hematopoietic stem cell transplantation
  4. Improving patient-physician research and enhancing communication
  5. Developing and testing palliative care intervention to optimize end-of-life care for patients with hematologic malignancies

Publications